Paul, Weiss
Matthew Leist
- Deals
- 7
- Latest
- Sep 2026
- Most deals in
- Food & Beverage
Firm
- Paul, Weiss Law firm · 2026 · 7 deals
Often works with
- Robert Holo 6 deals together
- William O’Brien 5 deals together
- Eric Wedel 5 deals together
- Caroline Epstein 5 deals together
- Chelsea Darnell 4 deals together
- James Langston 4 deals together
- Timothy Cruickshank 4 deals together
- Brian Krause 4 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Sep 2026 | 1.5-million-square-foot manufacturing and warehouse campus in Allentown, Pennsylvania | Keurig Dr Pepper | Chobani | Asset sale | Legal adviser to Keurig Dr Pepper (seller) | Announced | 125.0 | Food & Beverage+2 | Chobani acquisition of 1.5-million-square-foot manufacturing and warehouse campus in Allentown, Pennsylvania |
| Sep 2026 | Chobani | Keurig Dr Pepper | Chobani | Buy-back | Legal adviser to Keurig Dr Pepper (seller) | Announced | 800.0 | Dairy | Chobani share buy-back |
| Apr 2026 | Celerion | H.I.G. Capital affiliate | THL Partners | Acquisition | Legal adviser to THL Partners (acquirer) | Announced | – | Pharma Services+2 | THL Partners acquisition of Celerion |
| Feb 2026 | beverage and coffee businesses | Keurig Dr Pepper | – | Demerger | Legal adviser to Keurig Dr Pepper (seller) | Announced | – | Beverages+1 | beverage and coffee businesses demerger |
| Feb 2026 | JDE Peet's | – | Keurig Dr Pepper | Acquisition | Legal adviser to Keurig Dr Pepper (acquirer) | Completed | 18,378.0 | Coffee | Keurig Dr Pepper acquisition of JDE Peet's |
| Feb 2026 | TreeHouse Foods | – | Industrial F&B Investments III | Acquisition | Legal adviser to Investindustrial (acquirer) | Completed | 2,900.0 | Food+3 | Industrial F&B Investments III acquisition of TreeHouse Foods |
| Jan 2026 | NEFCO | – | Leonard Green & Partners | Acquisition | Legal adviser to Leonard Green & Partners, L.P. (acquirer) | Completed | – | Distribution+1 | Leonard Green & Partners acquisition of NEFCO |
Deals where Matthew Leist is named on the firm's deal team, by the firm or the press.